Back
Results - Announcements
Sales rise 18.03% to Rs 168.18 crore
Lincoln Pharmaceuticals consolidated net profit declines 37.74% in the March 2025 quarter
22-May-2025, 02:01
Net profit of Lincoln Pharmaceuticals declined 37.74% to Rs 11.58 crore in the quarter ended March 2025 as against Rs 18.60 crore during the previous quarter ended March 2024. Sales rose 18.03% to Rs 168.18 crore in the quarter ended March 2025 as against Rs 142.49 crore during the previous quarter ended March 2024.
Net profit of Lincoln Pharmaceuticals declined 37.74% to Rs 11.58 crore in the quarter ended March 2025 as against Rs 18.60 crore during the previous quarter ended March 2024. Sales rose 18.03% to Rs 168.18 crore in the quarter ended March 2025 as against Rs 142.49 crore during the previous quarter ended March 2024.
For the full year,net profit declined 11.74% to Rs 82.35 crore in the year ended March 2025 as against Rs 93.30 crore during the previous year ended March 2024. Sales rose 7.35% to Rs 623.23 crore in the year ended March 2025 as against Rs 580.55 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. | |
| Sales | 168.18 | 142.49 | 18 | 623.23 | 580.55 | 7 |
| OPM % | 15.89 | 12.90 | - | 16.28 | 17.21 | - |
| PBDT | 19.47 | 24.90 | -22 | 122.09 | 132.87 | -8 |
| PBT | 16.25 | 22.22 | -27 | 109.19 | 122.24 | -11 |
| NP | 11.58 | 18.60 | -38 | 82.35 | 93.30 | -12 |
Powered by Capital Market - Live News